Tcheng, J E <br/><br/>
Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.  [electronic resource] 

 -  The American journal of cardiology  Aug 1997 
 - 21B-28B p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(97)00573-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials, Phase III as Topic<br/>Drug Administration Schedule<br/>Eptifibatide<br/>Humans<br/>Myocardial Ischemia--mortality<br/>Peptides--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Survival Analysis<br/>Treatment Outcome